Effects of Mental Practice and Therapeutic Exercise in Mild Smokers

March 24, 2025 updated by: Francisco Martínez Arnau, University of Valencia

Effects of Mental Practice and Therapeutic Exercise in Mild Smokers: a Randomized Controlled Trial

The goal of this clinical trial is to learn about the effects who would add mental practice based on action observation to a therapeutic exercise program in young mild smokers.

The main question it aims to answer is whether the observation of actions prior to the implementation of a therapeutic exercise program improves the response to it on respiratory, strength and muscle function variables.

Participants will be assigned to one of 2 study groups:

G1) Therapeutic exercise plus action observation training (n=20) G2) Therapeutic exercise plus sham action observation training (n=20)

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Valencia, Spain, 46010
        • Universitat de València

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • >18 years old
  • Had a pack per year index of <5 (mild smoking index).

Exclusion Criteria:

Those who presented:

  • a respiratory pathology,
  • cardiac, systematic, or metabolic disease,
  • history of recent surgery,
  • vertebral fracture,
  • or osteoarticular disorders of the spine area.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Action observation plus exercise
Therapeutic exercise plus action observation training
Participants make an observation of actions related to the training they are going to perform before each session. Subsequently, they perform the therapeutic exercise program of 6 sessions in a period of 2 weeks.
Sham Comparator: Sham observation plus exercise
Therapeutic exercise plus sham action observation training
Participants make a sham observation before each session. Subsequently, they perform the therapeutic exercise program of 6 sessions in a period of 2 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory strength
Time Frame: Before the start of the program, in the middle of the program (1 week) and at the end of the program (2 weeks)
Maximal respiratory pressures (in H2O centimeters)
Before the start of the program, in the middle of the program (1 week) and at the end of the program (2 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spirometric parameters
Time Frame: Before the start of the program, in the middle of the program (1 week) and at the end of the program (2 weeks)
Forced expiratory volume in the first second FEV1 (in liters/second) and forced expiratory volume FVC (In liters/second) obtained from a spirometry
Before the start of the program, in the middle of the program (1 week) and at the end of the program (2 weeks)
Physical function
Time Frame: Before the start of the program, in the middle of the program (1 week) and at the end of the program (2 weeks)
5 times sit-to-stand test (in seconds)
Before the start of the program, in the middle of the program (1 week) and at the end of the program (2 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 30, 2023

Primary Completion (Actual)

April 28, 2024

Study Completion (Actual)

July 1, 2024

Study Registration Dates

First Submitted

October 6, 2023

First Submitted That Met QC Criteria

November 7, 2023

First Posted (Actual)

November 9, 2023

Study Record Updates

Last Update Posted (Actual)

March 28, 2025

Last Update Submitted That Met QC Criteria

March 24, 2025

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2023-FIS-2731776-2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smokers

Clinical Trials on Therapeutic exercise program plus action observation training

Subscribe